This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
Rituximab use in multiple sclerosis has been promising. Cytokine release
syndrome (CRS) is a common side effect of rituximab in patients with
lymphoma. We report a case of a 44-year-old man with a history of
relapsing-remitting multiple sclerosis, who presented with signs and
symptoms consistent with CRS after rituximab initiation.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.